SEC ownership of AVEO PHARMACEUTICALS, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001325879.

Comparable stake leader

Forest Baskett

Disclosed value leader

Forest Baskett

Comparable rows

0/6

Latest evidence

19 Jan 2023

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
19 Jan 2023
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001325879
Issuer location
Boston, MA

Ownership snapshot

Top shareholders of AVEO PHARMACEUTICALS, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Forest Baskett
Disclosed value leader
Forest Baskett
Comparable rows
0/6
Latest evidence
19 Jan 2023
3/4/5 Highest disclosed value: $48,300 6 rows are not safely comparable across share classes.

Quick read

Forest Baskett has the largest disclosed position value at $48.3K.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Forest Baskett's linked filing trail.
Disclosed position value Top 5
Forest Baskett $48.3K
Mohamad Makhzoumi $13.7K
Scott D. Sandell $5.8K
Anthony A. Florence Jr. $5.3K
Peter W. Sonsini $360

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Forest Baskett
3/4/5
10%+ Owner
class O/S missing
$48,300
3,220 shares
19 Oct 2022
Mohamad Makhzoumi
3/4/5
10%+ Owner
class O/S missing
$13,695
913 shares
19 Oct 2022
Scott D. Sandell
3/4/5
10%+ Owner
class O/S missing
$5,790
386 shares
19 Oct 2022
Anthony A. Florence Jr.
3/4/5
10%+ Owner
class O/S missing
$5,310
354 shares
19 Oct 2022
Peter W. Sonsini
3/4/5
10%+ Owner
class O/S missing
$360
24 shares
19 Oct 2022
Kenneth Bate
3/4/5
Director
class O/S missing
$5,625
375 shares
19 Jan 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 11 Jul 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to AVEO PHARMACEUTICALS, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Forest Baskett
Net 12M change
$0
Latest report
19 Jan 2023
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Forest Baskett 10%+ Owner $48,300 Mixed 19 Oct 2022
Mohamad Makhzoumi 10%+ Owner $13,695 Mixed 19 Oct 2022
Scott D. Sandell 10%+ Owner $5,790 Mixed 19 Oct 2022
Kenneth Bate Director $5,625 Mixed 19 Jan 2023
Anthony A. Florence Jr. 10%+ Owner $5,310 Mixed 19 Oct 2022
Peter W. Sonsini 10%+ Owner $360 Mixed 19 Oct 2022
Anthony B. Evnin Director Mixed 19 Jan 2023
NEA Partners 15, L.P. 10%+ Owner Mixed 19 Oct 2022
New Enterprise Associates 15, L.P. 10%+ Owner Mixed 19 Oct 2022
Jebediah Ledell Chief Operating Officer Mixed 19 Jan 2023
Erick Lucera Chief Financial Officer Mixed 19 Jan 2023
Scarlett Spring Director Mixed 19 Jan 2023
Growth Equity Opportunities Fund IV, LLC 10%+ Owner Mixed 19 Oct 2022
Michael P. Bailey President & CEO, Director Mixed 19 Jan 2023
Gregory T. Mayes Director Mixed 19 Jan 2023
Michael Ferraresso Chief Commercial Officer Mixed 19 Jan 2023
Kevin Joseph Cullen Director Mixed 19 Jan 2023
Corinne Epperly Director Mixed 19 Jan 2023

Recent insider transactions for AVEO PHARMACEUTICALS, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .